Rob Roth Email & Phone Number
@prilenia.com
3 phones found area 617
LinkedIn matched
Who is Rob Roth? Overview
A concise factual answer block for searchers comparing this professional profile.
Rob Roth is listed as Senior Vice President, Head of Commercial, Prilenia Therapeutics at Prilenia, based in Greater Boston, United States. AeroLeads shows a work email signal at prilenia.com, phone signal with area code 617, and a matched LinkedIn profile for Rob Roth.
Rob Roth previously worked as Senior Vice President, Head of Commercial at Prilenia and Vice President, Head of Commercial at Prilenia. Rob Roth holds Mba from The Tuck School Of Business At Dartmouth.
Email format at Prilenia
This section adds company-level context without repeating Rob Roth's masked contact details.
AeroLeads found 1 current-domain work email signal for Rob Roth. Compare company email patterns before reaching out.
About Rob Roth
Biopharma commercial leader with 25+ years of experience in commercial strategy, new product commercialization, marketing, corporate communications, commercial operations & analytics, patient advocacy and patient services. Extensive work in the U.S. and globally, focusing across physicians and patients. Background spans both premier larger companies and smaller start-ups. Motivated to build successful businesses by improving lives.
Listed skills include Global Marketing, Biotechnology, Pharmaceutical Industry, Neurology, and 29 others.
Rob Roth's current company
Company context helps verify the profile and gives searchers a useful next step.
Rob Roth work experience
A career timeline built from the work history available for this profile.
Vice President, Head Of Commercial
Lead marketing, commercial operations and sales to support the launch of a first-in-class lead product to treat Huntington’s disease, ALS, and other neurodegenerative diseases and neurodevelopmental disorders.
Vice President, Global Marketing & Patient Support
As a member of the Leadership Team, headed all U.S. and global marketing and patient support efforts for rare disease first product launch, and advancement of a portfolio of medicines to treat liver and gastrointestinal diseases. Built and guided high-performing team of internal staff and external partners. Orchestrated seamless Week 1 U.S. launch. Significantly exceeded internal expectations and analyst consensus launch revenue projections.
Vice President, Marketing, Corporate Communications & Patient Advocacy
Led commercialization planning, and headed all marketing, corporate communications and advocacy efforts for rare disease first product launch, and advancement of a portfolio of medicines to treat liver and gastrointestinal diseases. Led early commercial launch planning, including market research, brand strategy, commercialization plan, forecast, corporate communications strategy, market access strategy and patient support strategy. Supported business development efforts. Assembled and guided a high-performing team of internal staff and external partners.
Principal
Empower biopharma leaders with expertise in commercial strategy, marketing, corporate communications and patient advocacy. Core capabilities: corporate value story, brand strategy, launch planning, market assessment, market research, forecasting, life cycle management, branding, messaging/copywriting, promotional campaigns, patient advocacy, public relations, adherence, tactical/project management.Engagements:• Albireo Pharmaceuticals: Led commercial planning and prep. in rare pediatric liver disease.• Aldeyra Therapeutics: Led corporate development for ophthalmology/rare disease portfolio.• Biogen: Developed U.S. long-range plan and brand plan in spinal muscular atrophy.• Digital therapeutics company (confidential): Assisted with brand strategy and launch prep.• Mitochondrial disease company (confidential): Evaluated new therapeutic area.• Rare disease company (confidential): Assisted with U.S. launch planning.• Spero Therapeutics: Developed commercialization plan for launch in antibiotics.• Vida Ventures: Assessed commercial potential of emerging medical technology.
Vice President Of Marketing
Reporting to the CEO, led all aspects of commercial strategy and U.S. launch preparation for two innovative ophthalmology products. Company completed merger with Rocket Pharmaceuticals.• Developed brand strategy, forecast, launch plan and patient advocacy plan.• Evaluated payer landscape and developed market access strategy.• Led market research and analytics. • Led brand name development and packaging design.• Assessed market potential, guided strategy in new indications and evaluated BD opportunities.• Built commercial vision in support of IR and BD efforts.
Senior Director, Head Of Global Marketing, Rare Hematology Diseases
Led global marketing strategy for four products across two hematology disease areas, achieving the highest Gaucher patient total in 25 years and highest market share in >4 years.
Senior Director, Global Marketing, Cerdelga
Led successful launch of a transformative therapy to treat Gaucher disease, receiving Sanofi Champions for Customers Award (top 1% of employees worldwide).
Director, Global Marketing, Fabry Disease
Led cross-functional, worldwide relaunch team for Fabry disease therapy, developing relaunch strategy and driving execution to recapture market leadership after 2 ½-year supply shortage.
Associate Director, Global Neurology Marketing
Drove worldwide promotional strategy for new MS therapy, achieving blockbuster status in 2009.
Associate Director, Marketing, Japan
Directed marketing for first product launch in Japan and achieved Year 1 patient goal.
Senior Manager, Multiple Sclerosis Franchise Marketing
Managed range of U.S. physician and patient marketing tactics to drive performance of $1B market-leading product and launch of a second breakthrough product.
Senior Manager, Neurology Physician Marketing
Product Manager, Avonex Patient Marketing
Interim Area Business Manager
Communications Specialist
Public Affairs Intern
Rob Roth education
Mba
Bachelor Of Science (Bs), Journalism
Frequently asked questions about Rob Roth
Quick answers generated from the profile data available on this page.
What company does Rob Roth work for?
Rob Roth works for Prilenia.
What is Rob Roth's role at Prilenia?
Rob Roth is listed as Senior Vice President, Head of Commercial, Prilenia Therapeutics at Prilenia.
What is Rob Roth's email address?
AeroLeads has found 1 work email signal at @prilenia.com for Rob Roth at Prilenia.
What is Rob Roth's phone number?
AeroLeads has found 3 phone signal(s) with area code 617 for Rob Roth at Prilenia.
Where is Rob Roth based?
Rob Roth is based in Greater Boston, United States while working with Prilenia.
What companies has Rob Roth worked for?
Rob Roth has worked for Prilenia, Albireo Pharma, Inc., Roth Health Marketing & Communications, Llc, Inotek Pharmaceuticals Corporation, and Sanofi Genzyme.
How can I contact Rob Roth?
You can use AeroLeads to view verified contact signals for Rob Roth at Prilenia, including work email, phone, and LinkedIn data when available.
What schools did Rob Roth attend?
Rob Roth holds Mba from The Tuck School Of Business At Dartmouth.
What skills is Rob Roth known for?
Rob Roth is listed with skills including Global Marketing, Biotechnology, Pharmaceutical Industry, Neurology, Product Launch, Biopharmaceuticals, Commercialization, and Cross Functional Team Leadership.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial